Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
This clinical trial followed 40 participants in an inpatient facility for opioid use disorder (OUD) who reported an average of a 40% reduction in opioid cravings
Hydration Strategy Drinking enough water is about 1.5 to 2 liters a day
Behavioral Changes The appetite suppression and emotional eating reduction these medications promote can lead to long-term, positive lifestyle changes
Clean the vials rubber stopper with an alcohol swab before drawing a dose
The Phase 2 trial data suggests retatrutide produces greater weight loss than either semaglutide or tirzepatide at comparable timepoints
Retrieved from Zhao, Q., Chen, Y
US$ 27.97
US$ 22.04
US$ 26.27
US$ 26.12
US$ 23.52
.png)
US$ 24.55
US$ 22.96
US$ 27.32
US$ 25.60
